TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nakamura Läkarkonsult AB
Closing information (x1000 SEK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
2,015
|
2,720 | |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
253
|
2,720 | |
| EBITDA |
252
|
2,720 | |
| Total assets |
2,118
|
0 | |
| Current assets |
2,118
|
0 | |
| Current liabilities |
250
|
0 | |
| Equity capital |
1,868
|
2,770 | |
| - share capital |
50
|
50 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency | 88.2% | ||
| Turnover per employee |
672
|
907 | |
| Profit as a percentage of turnover |
12.6%
|
100% | |
| Return on assets (ROA) | 12.0% | ||
| Current ratio | 847.2% | ||
| Return on equity (ROE) |
13.5%
|
98.2% | |
| Change turnover |
-705
|
793 | |
| Change turnover % |
-10%
|
-26%
|
41% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
200% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.